Why the study?
Native T1 mapping supports decision-making in cardiomyopathies, but automated tissue characterisation frameworks with uncertainty-based quality control were needed.
Does an automated neural network framework with uncertainty-based quality control accurately quantify myocardial tissue characteristics from native T1 mapping compared to manual analysis in healthy subjects and cardiomyopathy patients?
Does an automated neural network framework with uncertainty-based quality control accurately quantify myocardial tissue characteristics from native T1 mapping compared to manual analysis in healthy subjects and cardiomyopathy patients?
An automated neural network pipeline with uncertainty-based quality control accurately quantifies myocardial native T1 mapping, enabling large-scale derivation of reference values.
Supports efficient T1 mapping for research scale; leaves open prospective validation before clinical adoption.
Tissue characterisation with cardiovascular magnetic resonance (CMR) parametric mapping has the potential to detect and quantify both focal and diffuse alterations in myocardial structure not assessable by late gadolinium enhancement. Native T 1 mapping in particular has shown promise as a useful biomarker to support diagnostic, therapeutic and prognostic decision-making in ischaemic and non-ischaemic cardiomyopathies. Convolutional neural networks (CNNs) with Bayesian inference are a category of artificial neural networks which model the uncertainty of the network output. This study presents an automated framework for tissue characterisation from native shortened modified Look-Locker inversion recovery ShMOLLI T 1 mapping at 1.5 T using a Probabilistic Hierarchical Segmentation (PHiSeg) network (PHCUMIS 119–127, 2019). In addition, we use the uncertainty information provided by the PHiSeg network in a novel automated quality control (QC) step to identify uncertain T 1 values. The PHiSeg network and QC were validated against manual analysis on a cohort of the UK Biobank containing healthy subjects and chronic cardiomyopathy patients (N=100 for the PHiSeg network and N=700 for the QC). We used the proposed method to obtain reference T 1 ranges for the left ventricular (LV) myocardium in healthy subjects as well as common clinical cardiac conditions. T 1 values computed from automatic and manual segmentations were highly correlated (r=0.97). Bland-Altman analysis showed good agreement between the automated and manual measurements. The average Dice metric was 0.84 for the LV myocardium. The sensitivity of detection of erroneous outputs was 91%. Finally, T 1 values were automatically derived from 11,882 CMR exams from the UK Biobank. For the healthy cohort, the mean (SD) corrected T 1 values were 926.61 (45.26), 934.39 (43.25) and 927.56 (50.36) for global, interventricular septum and free-wall respectively. The proposed pipeline allows for automatic analysis of myocardial native T 1 mapping and includes a QC process to detect potentially erroneous results. T 1 reference values were presented for healthy subjects and common clinical cardiac conditions from the largest cohort to date using T 1 -mapping images.
No takes yet. Share an insight, caveat, or question.
A 2020 study studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: